# Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors

> **NCT01625611** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 59 (actual)

## Conditions studied

- Alcohol Drinking

## Interventions

- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT01625611
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2022-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625611, "Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01625611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*